P1112: PATIENT-REPORTED OUTCOMES (PRO) AMONG PATIENTS WITH MANTLE CELL LYMPHOMA RECEIVING PIRTOBRUTINIB AFTER PRIOR COVALENT BTKI: INTERIM PRO ANALYSIS FROM THE BRUIN PHASE 1/2 STUDY
HemaSphere | August 8, 2023 | Volume: 7 | Issue: S3 | Pages: e34270c5
10.1097/01.hs9.0000971344.34270.c5